Can I buy a Dexcom in Germany without diabetes?

Dexcom sells two sensors in Germany through its own webshop: Dexcom G7 and Dexcom Flex. The shop pages list no prescription requirement, but they do say a Dexcom account is required. Both products are aimed at people with diabetes: the G7 at people who inject insulin several times a day, the Flex at adults with type 2 diabetes who are not on intensive insulin therapy. Dexcom's product for people without diabetes, Stelo, is sold only in the US.

How much does the Dexcom G7 cost in Germany if I pay myself?

In Dexcom's German webshop a single 10-day G7 sensor costs €99.00 and a 3-pack €269.00 (regular price €299.00), VAT included (as of 14 Oct 2026). That works out to €9.90 or €8.97 per day. The Dexcom Flex is much cheaper at €139.90 for two 15-day sensors, about €4.66 per day.

Is Dexcom Stelo available in Germany or the EU?

No. Stelo is sold only in the US. According to Oura, the Stelo app is only available in US app stores, Oura's Stelo integration is explicitly US-only, and stelo.com has no German or other European country page (as of 14 Oct 2026). Reports say Dexcom plans Stelo for the UK, Australia, New Zealand and South Korea; Germany is not on that list.

What is the difference between Dexcom G7 and Dexcom Flex?

The G7 lasts 10 days (plus a 12-hour grace period), connects to insulin pump systems and directly to the Apple Watch, and is meant for people on intensive insulin therapy. The Flex lasts 15 days (plus 12 hours), has been sold in Germany since 16 July 2026, and is meant for adults with type 2 diabetes who take tablets, GLP-1 drugs or at most basal insulin. Per day, the Flex costs about half as much.

Not confirmed. The extortion group ShinyHunters listed Dexcom on its leak site on 1 October 2026, and a second group called Redact claimed a ransomware attack on 10 October. According to reports, neither published data samples. Dexcom has not confirmed an incident (as of 12 Oct 2026). Three proposed class actions were nonetheless filed in the US; no court has ruled on them.

Is there a recall for the Dexcom G7?

No recall is known for sensors sold through regular channels in Germany. There were two safety notices in 2026, though: in June Dexcom warned about two stolen scrap lots sold in the US (check at dexcom.com/theft-check), and in September Germany's BfArM published a safety notice about G7 apps before version 2.12, where certain alerts may not vibrate in Do Not Disturb mode. The fix is an app update.

Dexcom Without Diabetes in Germany 2026: G7, Flex or Stelo?

Transparency: This blog has never worn a Dexcom sensor or any other CGM. There are no first-party readings here. The article is based on Dexcom’s shop pages (accessed 14 Oct 2026), press releases, safety notices from Germany’s BfArM and Spain’s AEMPS, a pivotal accuracy study and the JAMA review from August 2026. All sources are listed at the end. This article contains no affiliate links. More on methodology

Key points

Available in Germany: Dexcom G7 and Dexcom Flex, both only through Dexcom’s webshop. No prescription according to the shop, but you need a Dexcom account.
Not available in Germany: Stelo, Dexcom’s sensor for people without diabetes. It is sold only in the US.
Intended use: The G7 is built for people who inject insulin several times a day. The Flex is for adults with type 2 diabetes who are not on intensive insulin therapy. Neither is meant for healthy people.
Cost: G7 works out to €8.97–9.90 per day, Flex to €4.22–4.66 per day.
Benefit for healthy people: not shown, but not disproven either. The JAMA review from August 2026 finds only “limited and indirect evidence” even for prediabetes.
Current (October 2026): unconfirmed hacker claims against Dexcom, a safety notice for the G7 app, and Q3 results on 29 October.

What Dexcom sells in Germany

Dexcom (DexCom, Inc., Nasdaq: DXCM) was founded in 1999 and is headquartered in San Diego. Its German subsidiary is Dexcom Deutschland GmbH in Mainz. The German webshop lists exactly two sensors: G7 and Flex. The older G6 has been out of production since 1 July 2026.

	Dexcom G7	Dexcom Flex	Stelo
Available in Germany	✅ Dexcom webshop	✅ Dexcom webshop, since 16 Jul 2026	❌ US only
Intended for (per manufacturer)	People who inject insulin several times a day	Adults with type 2 diabetes not on intensive insulin therapy	Adults 18+ not on insulin (US)
Wear time	10 days + 12 h grace period	15 days + 12 h grace period	up to 15 days
Warm-up	max. 30 minutes	max. 30 minutes	–
Price	€99.00 per sensor, €269.00 for a 3-pack	€139.90 for 2 sensors, subscription €129.90, 3-month subscription €379.90	$99 one-off, $89 monthly subscription (US)
Per day (calculated)	€9.90 (single), €8.97 (3-pack)	€4.66 (monthly pack), €4.33 (subscription), €4.22 (3-month subscription)	–
Published accuracy	MARD 8.2% on the upper arm (study in adults with diabetes)	no MARD figure found on the German pages	–

Prices incl. VAT per Dexcom’s German webshop and stelo.com, as of 14 Oct 2026. The per-day figures are our own arithmetic and assume every sensor lasts its full wear time; the grace period is not counted.

Dexcom G7: the sensor for insulin users

The G7 is Dexcom’s main product. It sends a reading every five minutes to a phone, a receiver or directly to the Apple Watch, and it connects to insulin pump systems. Dexcom’s German webshop describes it as the sensor “for people who inject insulin several times a day”.

There is a pivotal accuracy study (Garg et al., Diabetes Technology & Therapeutics, 2022): in 316 adults with type 1 or type 2 diabetes, the mean absolute relative difference from the lab reference (MARD) was 8.2% on the upper arm and 9.1% on the abdomen. Important for healthy users: these numbers come from people with diabetes.

A 15-day version of the G7 exists in the US. Dexcom’s German webshop lists only the 10-day sensor, and according to Diabetes-Anker Dexcom has not given a German launch date for the 15-day version.

Dexcom Flex: the cheaper Dexcom for type 2

The Flex has been on sale in Germany since 16 July 2026; Germany was the first market. It lasts 15 days, weighs 3.3 g and is waterproof according to Dexcom. Readings go to the Flex app or to a separate receiver (€69.90), or both at once.

On its product page Dexcom says the Flex is suitable if “you live with type 2 diabetes and do not use insulin or only receive basal insulin”. The launch press release names adults 18+ with type 2 diabetes who take basal insulin, tablets or GLP-1 drugs. People without diabetes do not appear in either description.

According to the patient association Diabetiker Niedersachsen, Dexcom is promoting a discounted 30-day trial for new customers with type 2 diabetes until the end of 2026.

Stelo: the Dexcom for healthy people, but US only

Stelo is Dexcom’s over-the-counter sensor for adults who do not take insulin, which includes people without diabetes. It is sold only in the US:

stelo.com has no country page for Germany, the UK or Australia; those addresses return a 404 error (checked 14 Oct 2026).
According to Oura, the Stelo app is only available in US app stores.
Oura’s glucose feature with Stelo is “available only in the US”, per Oura support. The former German Oura shop page for Stelo now redirects to exactly that support article.

According to industry reports from May and June 2026, Dexcom plans to launch Stelo in the UK, Australia, New Zealand and South Korea. Germany is not on that list. A US import fails at the app.

Correction: Several older articles on this site said Stelo could be ordered via Oura’s German shop. That was wrong and has been corrected as of 14 Oct 2026.

Can I buy a Dexcom as a healthy person?

The G7 and Flex shop pages list no prescription requirement, but they do say “Dexcom account required”. Whether Dexcom asks about a diagnosis when you open the account is not stated on the pages. We have not tried it.

The intended use matters more. A CGM is a medical device. Wearing one without diabetes means using it outside what the manufacturer built, tested and labelled it for. In practice:

The accuracy data applies to people with diabetes. There is no Dexcom study in healthy people.
The apps are built for therapy. Alerts, target ranges and reports are designed around hypoglycaemia and insulin, not around what your breakfast does to your curve.
Insurance will not pay. In Germany, reimbursement for real-time CGM is tied to insulin-treated diabetes.

That is not a prohibition. It is context: you are buying a diabetes tool, not a biohacking gadget.

Does a CGM do anything for healthy people?

Honest answer: nobody knows. The review “Continuous Glucose Monitoring in Type 2 Diabetes and Beyond” (Dower et al., JAMA Internal Medicine, 3 August 2026) says this about the groups closest to healthy people:

“Only limited and indirect evidence supported the adoption of CGM in people with type 2 diabetes not receiving glucose-lowering therapy or in those with prediabetes or obesity.”

Metabolically healthy people do not appear in the review at all. That is a gap in the evidence, not proof that CGMs are useless. The studies Dexcom cites for the Flex come from type 2 diabetes care and cannot be transferred to healthy people.

If you measure anyway, treat it as a bounded self-experiment: two to four weeks, one clear question (for example: how do I respond to oats versus eggs?), then stop. What a CGM does not replace: an HbA1c test from your doctor if you are worried about your blood sugar.

What is going on at Dexcom (as of 14 Oct 2026)

Dexcom has been showing up noticeably often in searches since early October 2026. We did not find a single event that clearly explains it. These items fit the timing:

1. Hacker claims, unconfirmed. The extortion group ShinyHunters added Dexcom to its leak site on 1 October and threatened to publish data (Cybernews). On 10 October a second group called Redact claimed a ransomware attack on Dexcom’s US operations. According to MedDevice Cyber, neither group published data samples, and Dexcom has not confirmed an incident (as of 12 Oct). Three proposed class actions were nonetheless filed in the US between 2 and 6 October. These are allegations; no court has ruled. There is currently no confirmed impact on users in Germany.

2. Safety notice for the G7 app. On 16 Sep 2026 Germany’s BfArM published a manufacturer notice (reference 39037/26): in G7 apps for iOS, Apple Watch and Android before version 2.12, critical alerts may not vibrate in Do Not Disturb mode, and some system alerts may stay silent for up to 25 minutes. According to Dexcom, no serious injuries occurred. The fix is the app update. Spain’s AEMPS followed on 6 Oct 2026 and describes a second issue: in iOS version 2.12, non-critical alerts may not sound in silent or Focus mode.

3. Stolen scrap sensors (June 2026). According to Dexcom, two G7 lots that were meant to be destroyed as scrap were stolen and sold in the US by an unauthorised distributor. The affected lots are 1725204004 and 1725069002. According to the safety notice (BfArM reference 22117/26), small quantities were also sold outside the US. Products from authorised channels are not affected. You can check your serial number at dexcom.com/theft-check.

4. Dates. Dexcom reports Q3 results on 29 October 2026. The G6 has been out of production since 1 July 2026.

What are the alternatives in Germany?

The two sensors that are explicitly built for people without diabetes, Stelo and Abbott Lingo, are not officially sold in Germany. What remains:

FreeStyle Libre 3 Plus (Abbott): available from pharmacies and from Abbott, 15-day wear, €70.60 per sensor on Abbott’s subscription (€4.71 per day). It is a diabetes product too. Important: Libre 3 and Libre 3 Plus are under an FDA Class I recall (falsely low readings), and Germany is in scope. Check the serial number in the lot checker before applying a sensor. Details in our Lingo vs Libre 3 Plus article.
Dexcom Flex: the cheapest Dexcom per day, but with a type 2 intended use (see above).
Abbott Lingo: US and UK only.

For more on whether CGMs make sense without diabetes at all, see our Libre 3 guide for non-diabetics.

Verdict

If you search for “Dexcom” in Germany and do not have diabetes, the short answer is: the Dexcom built for you is called Stelo, and you cannot get it here. You can order the G7 and Flex from the webshop, but both are diabetes products. Per day, the Flex costs half as much as the G7 and lasts 15 instead of 10 days. Whether a CGM is worth it for healthy people at all is an open question. If you try one, plan it as a short experiment with a clear question.

The hacker reports around Dexcom are so far claims without evidence. What G7 users can actually do: update the app.

Sources

Dexcom webshop Germany, overview and target groups: dexcom.com/de-DE/webshop-home
Dexcom G7 sensor (€99.00) and 3-pack (€269.00): dexcom.com/de-de/dexcom-shop/g7/stp-gt-002, dexcom.com/de-de/dexcom-shop/g7/virg7003
Dexcom Flex shop and product page (prices, specs, suitability): dexcom.com/de-de/dexcom-shop/flex, monthly pack
Dexcom press release on the Flex launch, 16 Jul 2026 (German): presseportal.de
Stelo prices and intended use (US): stelo.com
Oura support, Stelo integration US only: support.ouraring.com
Stelo expansion to UK, Australia, New Zealand and South Korea: Drug Delivery Business, 18 May 2026
Garg SK et al.: Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. Diabetes Technol Ther 2022;24(6):373–380. PubMed 35157505
Dower et al.: Continuous Glucose Monitoring in Type 2 Diabetes and Beyond: A Review. JAMA Intern Med, 3 Aug 2026. DOI 10.1001/jamainternmed.2026.2772
BfArM, urgent safety information on Dexcom G7 (apps before 2.12), 16 Sep 2026: bfarm.de
AEMPS, information note PS 42/2026 on Dexcom G7 apps, 6 Oct 2026: aemps.gob.es
BfArM, safety notice on stolen G7 lots, 17 Jun 2026: bfarm.de
Cybernews on the ShinyHunters claim, 1 Oct 2026: cybernews.com
MedDevice Cyber on ShinyHunters and Redact: meddevicecyber.com
Overview of the US class actions: openclassactions.com
Diabetes-Anker on the end of G6 production and the 15-day version (German): diabetes-anker.de
Diabetiker Niedersachsen on the Flex trial offer and CGM reimbursement (German): diabetiker-nds.de
Dexcom Investor Relations, Q3 results date: investors.dexcom.com
FreeStyle Libre 3 Plus, subscription price (German): freestylelibre.de

Not affiliated with Dexcom. “Dexcom”, “Dexcom G7”, “Dexcom Flex” and “Stelo” are trademarks of Dexcom, Inc. This article is not medical advice. As of 14 October 2026.